Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
132.60    1.80 (1.38%)
Bid:
131.40
Ask:
132.60
Spread: 1.20 (0.913%)
Market Cap: £272.52m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Grant under Long Term Incentive Plan

11 Jun 2026 14:52

RNS Number : 9923H
Forterra plc
11 June 2026
 

11 June 2026

Forterra plc

Grant under Long Term Incentive Plan ("LTIP")

Forterra plc (the "Company") announces that on 11 June 2026 awards over ordinary shares of £0.01 each in the capital of the Company were granted to the Chief Executive Officer and persons discharging managerial responsibility ("PDMRs") under the Forterra plc LTIP as follows:

Name of Director / PDMR

Number of Shares awarded pursuant to Restricted Share Award

Number of Shares awarded pursuant to Performance Share Award

Neil Ash

(Chief Executive Officer) 

139,286

278,572

Mark Davies

(Chief Operations Officer)

27,669

55,339

Sarah Renton

(Group People Director)

20,123

40,246

James Cornish

(Commercial Director)

22,359

44,718

Nicola Chapman

(Strategy and Marketing Director)

15,651

31,303

Frances Tock

(Company Secretary)

7,990

15,980

Other management

 

55,252

110,504

Total awards granted

 

288,331

576,662

The terms of the awards align to the new hybrid award policy set out in the Directors' Remuneration Policy approved on the 19th of May 2026 at the 2026 Annual General Meeting and as described in the Annual Report and Accounts 2025.

No consideration was paid for the grant of the awards which are structured as nominal cost options at an option exercise price of £0.01 per Ordinary Share. The number of Ordinary Shares granted under the award has been calculated using a share price of £1.73 being an average mid-market quotation as derived from the London Stock Exchange Daily Official List for the share price averaged over six months, as per the RNS of 12 May 2026, which was within the applicable policy and plan rules limit when calculated in accordance with the plan rules.

Subject to the LTIP rules, the awards will normally vest on 11 June 2029, subject to the achievement of the performance conditions or underpin conditions (as relevant) and the participant being a Director or employee of the Company at that time.

 

The vesting of Performance Share Awards is subject to the satisfaction of performance conditions which have been set by the Remuneration Committee of the Board of Directors of the Company and are set out below:

Plan conditions

Performance condition

% of award subject to condition

Growth

% of PSP award which will vest

Adjusted EPS growth reported for the year ending 31 December 2028

45%

<5%

0%

Equal to 5%

25%

10% or above

100%

Company's total TSR against TSR of index members (FTSE 250 excluding investment trusts) - measured at 31 December 2028

45%

<Median

0%

Median

25%

Upper quartile or above

100%

Reduction in Group's clay product carbon emissions intensity versus 2025 baseline measured at 31 December 2028

10%

<5%

0%

5%

25%

10% or above

100%

Vesting is measured on a straight-line basis between the above performance points

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations and Listing Rule 9.3.2R.

Enquiries

Forterra plc:

Frances Tock (Company Secretary)

+44 (0) 1604 707 600

FTI Consulting (public relations adviser to Forterra):

+44 (0) 20 3727 1340

Richard Mountain

Vicky Hayns

Further information relating to the Company and its group can be found at: www.forterra.co.uk/investors

 

LEI: 213800O5DD6ATBVJAD23

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUGAQUPQGWG
Date   Source Headline
5th Oct 20215:49 pmRNSEmployee Benefit Trust Share Purchase
28th Sep 20219:28 amRNSEmployee Benefit Trust Share Purchase
23rd Sep 20218:33 amRNSHolding(s) in Company
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.